HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (Nasdaq:ARDM) (the “Company”) will host a corporate update conference call at 9:00 am ET (6:00 am PT) on Wednesday, January 6, 2016.
The Company will review recent progress with the Pulmaquin® investigational inhaled antibiotic program in non-cystic fibrosis bronchiectasis.
